Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy

C.R. Garrett, L.L. Siu, A. El-Khoueiry, J. Buter, C.M. Rocha-Lima, J. Marshall, P. LoRusso, P. Major, J. Chemidlin, O. Mokliatchouk, L. Velasquez, W. Hayes, D. Feltquate, S. Syed, S. Ford, G. Kollia, S. Galbraith, D.S.A. Nuyten

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)44-52
JournalBritish journal of cancer
Issue number1
Publication statusPublished - 2011

Cite this